We recently showed that MCMVIVL, a recombinant MCMV vaccine expressing the 533IYSTVASSL541 epitope (IVL) from the IAV HA protein, protects against influenza challenge when administered intranasally by inducing mucosal-resident CD8+ T cells [37]. The gene discussed is CD8A; the disease is influenza.